In continuation to our letter dated 2nd February, 2026 and pursuant to Regulation 33, 30 and other applicable regulations, if any, of the Securities and Exchange Board of India (Listing ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.8 pts less than Nifty Microcap 250 and 5.0 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Polychem Ltd's board, meeting on 9th February 2026, approved the unaudited standalone and consolidated financial results for Q3 and 9M ended December 31, 2025, with a clean review report from statutory auditor M/s. Nayan Parikh & Co. On a standalone basis, Q3 net sales declined about 16% YoY to Rs. 514.36 lakhs, but net profit rose roughly 29% to Rs. 81.93 lakhs thanks to lower raw material costs and higher other income. For 9M FY26 standalone, net sales grew about 10% to Rs. 1,861 lakhs with net profit up about 12% to Rs. 312.71 lakhs. On a consolidated basis, the picture is dominated by a large one-time gain of Rs. 2,899 lakhs in Q3 from fair-value re-measurement of investments, which pushed consolidated net profit to Rs. 2,547 lakhs for the quarter. The board also approved the re-appointment of Mr. Parthiv T. Kilachand as Managing Director for 3 years from 1st April 2026, subject to shareholder approval via postal ballot.
Core standalone operations are mixed — topline softness in Q3 but profitability improving on cost control. The headline consolidated profit surge is driven almost entirely by a non-operating fair-value investment gain and is not recurring, so investors should look at underlying earnings rather than the reported consolidated PAT.